Literature DB >> 8621513

Different single receptor domains determine the distinct G protein coupling profiles of members of the vasopressin receptor family.

J Liu1, J Wess.   

Abstract

The vasopressin receptor family is unique among all classes of peptide receptors in that its individual members couple to different subsets of G proteins. The V1a vasopressin receptor, for example, is preferentially linked to G proteins of the Gq/11 class (biochemical response: stimulation of phosphatidylinositol hydrolysis), whereas the V2 vasopressin receptor is selectively coupled to Gs (biochemical response: stimulation of adenylyl cyclase). To elucidate the structural basis underlying this functional heterogeneity, we have systematically exchanged different intracellular domains between the V1a and V2 receptors. Transient expression of the resulting hybrid receptors in COS-7 cells showed that all mutant receptors containing V1a receptor sequence in the second intracellular loop were able to activate the phosphatidylinositol pathway with high efficiency. On the other hand, only those hybrid receptors containing V2 receptor sequence in the third intracellular loop were capable of efficiently stimulating cAMP production. These findings suggest that the differential G protein coupling profiles of individual members of a structurally closely related receptor subfamily can be determined by different single intracellular receptor domains.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8621513     DOI: 10.1074/jbc.271.15.8772

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  17 in total

1.  Characterization of a novel nonpeptide vasopressin V(2)-agonist, OPC-51803, in cells transfected human vasopressin receptor subtypes.

Authors:  S Nakamura; Y Yamamura; S Itoh; T Hirano; K Tsujimae; M Aoyama; K Kondo; H Ogawa; T Shinohara; K Kan; Y Tanada; S Teramoto; T Sumida; S Nakayama; K Sekiguchi; T Kambe; G Tsujimoto; T Mori; M Tominaga
Journal:  Br J Pharmacol       Date:  2000-04       Impact factor: 8.739

2.  A hypothesis for GPCR activation.

Authors:  Jerzy Ciarkowski; Magdalena Witt; Rafał Slusarz
Journal:  J Mol Model       Date:  2005-05-12       Impact factor: 1.810

3.  Expression of human muscarinic cholinergic receptors in tobacco.

Authors:  J H Mu; N H Chua; E M Ross
Journal:  Plant Mol Biol       Date:  1997-05       Impact factor: 4.076

4.  Concurrent stimulation of cannabinoid CB1 and dopamine D2 receptors augments cAMP accumulation in striatal neurons: evidence for a Gs linkage to the CB1 receptor.

Authors:  M Glass; C C Felder
Journal:  J Neurosci       Date:  1997-07-15       Impact factor: 6.167

5.  A serine cluster prevents recycling of the V2 vasopressin receptor.

Authors:  G Innamorati; H M Sadeghi; N T Tran; M Birnbaumer
Journal:  Proc Natl Acad Sci U S A       Date:  1998-03-03       Impact factor: 11.205

Review 6.  Extramembranous Regions in G Protein-Coupled Receptors: Cinderella in Receptor Biology?

Authors:  Sreetama Pal; Amitabha Chattopadhyay
Journal:  J Membr Biol       Date:  2019-08-30       Impact factor: 1.843

7.  Molecular cloning, sequencing and phylogeny of vasotocin receptor genes in the air-breathing catfish Heteropneustes fossilis with sex dimorphic and seasonal variations in tissue expression.

Authors:  Arpana Rawat; Radha Chaube; Keerikkattil P Joy
Journal:  Fish Physiol Biochem       Date:  2015-01-18       Impact factor: 2.794

8.  PKD1-Dependent Renal Cystogenesis in Human Induced Pluripotent Stem Cell-Derived Ureteric Bud/Collecting Duct Organoids.

Authors:  Shohei Kuraoka; Shunsuke Tanigawa; Atsuhiro Taguchi; Akitsu Hotta; Hitoshi Nakazato; Kenji Osafune; Akio Kobayashi; Ryuichi Nishinakamura
Journal:  J Am Soc Nephrol       Date:  2020-08-03       Impact factor: 10.121

9.  Targeting V1A-vasopressin receptors with [Arg6, D-Trp7,9, NmePhe8]-substance P (6-11) identifies a strategy to develop novel anti-cancer therapies.

Authors:  Alison C MacKinnon; Uzma Tufail-Hanif; Mark Wheatley; Adriano G Rossi; Christopher Haslett; Michael Seckl; Tariq Sethi
Journal:  Br J Pharmacol       Date:  2009-01       Impact factor: 8.739

10.  Molecular modeling of the human vasopressin V2 receptor/agonist complex.

Authors:  C Czaplewski; R Kaźmierkiewicz; J Ciarkowski
Journal:  J Comput Aided Mol Des       Date:  1998-05       Impact factor: 3.686

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.